M&A Deal Summary |
|
|---|---|
| Date | 2019-02-26 |
| Target | Mr. Natural Productions |
| Sector | Consumer Products |
| Buyer(s) | Australis Capital |
| Deal Type | Buyout (LBO, MBO, MBI) |
| Deal Value | 1M USD |
SEARCH BY
Australis Capital is a publicly traded investment group focused on the cannabis industry. The Firm looks to provide equity and/or debt to public and private companies, offer financing in exchange for royalties or other distribution streams, as well as make controlling acquisitions. Australis Capital was formed in 2018 and is headquartered in Vancouver, British Columbia.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 6 |
| Sector: Consumer Products M&A | 1 of 1 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 2 of 2 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 3 of 3 |
| Year: 2019 M&A | 2 of 2 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-01-14 |
Folium Biosciences
Colorado Springs, Colorado, United States Folium Biosciences is a vertically integrated B2B producer, manufacturer, and distributor of hemp-derived non-psychoactive cannabinoids. Built on the core tenants of quality, science, scale, and innovation, Folium Biosciences controls all aspects of the supply chain from genetics and extraction to bulk and finished products. Folium Biosciences was founded in 2014 and is based in Colorado Springs, Colorado. |
Buy | - |
